Tumor cell contamination in re-infused stem cell autografts: does it have clinical significance?
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 41 (2) , 241-250
- https://doi.org/10.1016/s1040-8428(01)00160-3
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin’s lymphoma and Hodgkin’s disease: a clinical and molecular analysisBone Marrow Transplantation, 1999
- Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancyCurrent Opinion in Oncology, 1999
- CD34+‐selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: tumour cell contamination and outcomeBritish Journal of Haematology, 1999
- Collection, Tumor Contamination, and Engraftment Kinetics of Highly Purified Hematopoietic Progenitor Cells to Support High Dose Therapy in Multiple MyelomaBlood, 1998
- Lymphoma Cell Burden in Progenitor Cell Grafts Measured by Competitive Polymerase Chain Reaction: Less Than One Log Difference Between Bone Marrow and Peripheral Blood SourcesBlood, 1998
- Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantationBone Marrow Transplantation, 1997
- An update from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry on current activity in hematopoietic stem cell transplantationCurrent Opinion in Hematology, 1997
- Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patientsBritish Journal of Haematology, 1994
- Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrowBlood, 1994
- Immunologic Purging of Marrow Assessed by PCR before Autologous Bone Marrow Transplantation for B-Cell LymphomaNew England Journal of Medicine, 1991